| 000 | 01251 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515022720.0 | ||
| 264 | 0 | _c20060810 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a0085-2538 | ||
| 024 | 7 |
_a10.1038/sj.ki.5000222 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRodriguez-Iturbe, B | |
| 245 | 0 | 0 |
_aArteriolar remodeling in essential hypertension: are connective tissue growth factor and transforming growth factor involved? _h[electronic resource] |
| 260 |
_bKidney international _cApr 2006 |
||
| 300 |
_a1104-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 |
_aAmlodipine _xadverse effects |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadverse effects |
| 650 | 0 | 4 |
_aArterioles _xphysiopathology |
| 650 | 0 | 4 | _aConnective Tissue Growth Factor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aImmediate-Early Proteins _xphysiology |
| 650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xphysiology |
| 650 | 0 | 4 |
_aLosartan _xtherapeutic use |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xphysiology |
| 773 | 0 |
_tKidney international _gvol. 69 _gno. 7 _gp. 1104-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.ki.5000222 _zAvailable from publisher's website |
| 999 |
_c16214733 _d16214733 |
||